KAYLA ANTHONY: Open Payments
NPI 1639639412 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,027 in 120 payments from 19 companies in 2025. Trend: 2023 $811 · 2024 $2,300 · 2025 $3,027
Food & beverage: $3,027
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $493 |
| Otsuka America Pharmaceutical, Inc. | 12 | $395 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $365 |
| Janssen Pharmaceuticals, Inc | 8 | $311 |
| E.R. Squibb & Sons, L.L.C. | 7 | $179 |
| Neuronetics, Inc. | 1 | $165 |
| Lundbeck LLC | 5 | $147 |
| Alkermes, Inc. | 6 | $137 |
| Corium, LLC | 11 | $136 |
| Bausch Health US, LLC | 4 | $103 |
Products named: REXULTI, VRAYLAR, CAPLYTA, SPRAVATO, COBENFY, NEUROSTAR TMS THERAPY SYSTEM, Azstarys, LYBALVI.
Industry payments across FL — which companies pay providers there.
